| AMINOV, Rustam, Jonathan CAPLIN, Nina CHANISHVILI, Aidan COFFEY, Ian COOPER, Daniel DE VOS, Jiří DOŠKAŘ, Ville-Petri FRIMAN, İpek KURTBӦKE, Roman PANTŮČEK, Jean-Paul PIRNAY, Grégory RESCH, Christine ROHDE, Wilbert SYBESMA a Johannes WITTMANN. Application of bacteriophages. Microbiology Australia. Clayton, VIC, Australia: CSIRO Publishing, 2017, roč. 38, č. 2, s. 63-66. ISSN 1324-4272. doi:10.1071/MA17029. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1389544,
author = {Aminov, Rustam and Caplin, Jonathan and Chanishvili, Nina and Coffey, Aidan and Cooper, Ian and De Vos, Daniel and Doškař, Jiří and Friman, VilleandPetri and Kurtbӧke, İpek and Pantůček, Roman and Pirnay, JeanandPaul and Resch, Grégory and Rohde, Christine and Sybesma, Wilbert and Wittmann, Johannes},
article_location = {Clayton, VIC, Australia},
article_number = {2},
doi = {http://dx.doi.org/10.1071/MA17029},
keywords = {Phage therapy; bacteriophage; clinical trials; Nagoya Protocol; food safety; bacterial resistance},
language = {eng},
issn = {1324-4272},
journal = {Microbiology Australia},
title = {Application of bacteriophages},
url = {http://microbiology.publish.csiro.au/?paper=MA17029},
volume = {38},
year = {2017}
}
TY - JOUR
ID - 1389544
AU - Aminov, Rustam - Caplin, Jonathan - Chanishvili, Nina - Coffey, Aidan - Cooper, Ian - De Vos, Daniel - Doškař, Jiří - Friman, Ville-Petri - Kurtbӧke, İpek - Pantůček, Roman - Pirnay, Jean-Paul - Resch, Grégory - Rohde, Christine - Sybesma, Wilbert - Wittmann, Johannes
PY - 2017
TI - Application of bacteriophages
JF - Microbiology Australia
VL - 38
IS - 2
SP - 63-66
EP - 63-66
PB - CSIRO Publishing
SN - 13244272
KW - Phage therapy
KW - bacteriophage
KW - clinical trials
KW - Nagoya Protocol
KW - food safety
KW - bacterial resistance
UR - http://microbiology.publish.csiro.au/?paper=MA17029
L2 - http://microbiology.publish.csiro.au/?paper=MA17029
N2 - The emergence of antibiotic-resistant bacteria and decrease in the discovery rate of novel antibiotics takes mankind back to the ‘pre-antibiotic era’ and search for alternative treatments. Bacteriophages have been one of promising alternative agents which can be utilised for medicinal and biological control purposes in agriculture and related fields. The idea to treat bacterial infections with phages came out of the pioneering work of Félix d‘Hérelle but this was overshadowed by the success of antibiotics. Recent renewed interest in phage therapy is dictated by its advantages most importantly by their specificity against the bacterial targets. This prevents complications such as antibiotic-induced dysbiosis and secondary infections. This article is compiled by the participants of the Expert Round Table conference ‘Bacteriophages as tools for therapy, prophylaxis and diagnostics’ (19–21 October 2015) at the Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. The first paper from the Round Table was published in the Biotechnology Journal1. This In Focus article expands from this paper and includes recent developments reported since then by the Expert Round Table participants, including the implementation of the Nagoya Protocol for the applications of bacteriophages.
ER -
AMINOV, Rustam, Jonathan CAPLIN, Nina CHANISHVILI, Aidan COFFEY, Ian COOPER, Daniel DE VOS, Jiří DOŠKAŘ, Ville-Petri FRIMAN, İpek KURTBӦKE, Roman PANTŮČEK, Jean-Paul PIRNAY, Grégory RESCH, Christine ROHDE, Wilbert SYBESMA a Johannes WITTMANN. Application of bacteriophages. \textit{Microbiology Australia}. Clayton, VIC, Australia: CSIRO Publishing, 2017, roč.~38, č.~2, s.~63-66. ISSN~1324-4272. doi:10.1071/MA17029.
|
